Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2017 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management describe the company as currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event at the end, and that the cost is real and currently landing in results, and that the wait is the main current work, and the far side is specific and near-dated. We need to find if management conveys such a situation. The transcript covers Q4 2017 earnings. They discuss investments in R&D, sales and marketing, new products, acquisitions, etc. But is there a specific "waiting period" where they are paying now for something not yet earning, with a specific near-dated event? For example, they mention launching new products like Gauge and Bridge Perform, and acquiring Practice. They talk about investing in these. But do they describe a defined interval where they are bearing costs before benefits arrive? They mention that they are investing heavily in R&D and sales and marketing, but that's normal growth investment. They also mention that they expect to continue investing. They don't seem to describe a specific "waiting period" with a specific end date. They talk about product launches, but those are already launched. They talk about Practice acquisition, but that's already integrated and generating revenue. They mention that they are expanding internationally, but that's ongoing. The question is looking for a situation like: "We are currently paying for a new facility that will open in six months, and until then we are incurring costs without revenue." Or "We have hired a sales force that is being trained and will start selling next quarter." But in the transcript, they talk about hiring and expanding sales force, but they also say they are getting leverage from existing sales force. They mention that they are not growing Bridge sales force much, but focusing on quota expansion. They mention adding a few for Practice. That doesn't seem like a defined waiting period. They also mention that they expect to end 2018 with same cash balance as 2017, implying they are burning cash but that's normal. The key is: is there a specific near-dated event that will end the waiting period? They mention product launches, but those are already done. They mention that they will continue to invest.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.